Medtronic is closer to VenaSeal coverage: Here’s how

Medtronic is touting its new CPT codes for the VenaSeal varicose vein closure device – codes that company officials think bring the device closer to positive coverage from public and private insurers in the U.S. CMS announced the new codes on Nov. 1 as part of final rules for the 2018 Medicare Physician Fee Schedule (CMS-1676-F)

Humacyte lands $14 million to expand uses for human acellular vessel

Humacyte said today that it landed a $14.1 million award from the California Institute for Regenerative Medicine to support a clinical trial comparing its human acellular vessel, Humacyl, to arteriovenous fistulas – the traditional way to create vascular access in patients who need hemodialysis. The Research Triangle Park, N.C.–based company said it plans to evaluate Humacyl

Medtech stories we missed this week: August 4, 2017

From MDCorp inking a European distribution deal to Align Technology’s North Carolina expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. MDCorp inks distribution deal with Smart Endoscope Systems MDCorp announced in a July 31 press release that it has signed a distribution agreement with Smart Endoscope

Amaranth Medical looks to recapture the potential of bioresorbable scaffolds

Dr. Antonio Colombo had finished his presentation of 9-month data for Amaranth Medical‘s Aptitude sirolimus-eluting bioresorbable scaffold when an audience member asked about adverse events. He told the EuroPCR attendee that they hadn’t seen any adverse events related to the device during the trial – and that’s unusual. Bioresorbable scaffolds, like Abbott‘s (NYSE:ABT) Absorb, have been

Growing human hearts: The answer is spinach leaves?

We could someday be using spinach to grow human hearts, thanks to new research from the Worcester Polytechnic Institute, the University of Wisconsin-Madison and Arkansas State University. One of the problems that researchers have faced is how to create a vascular system that can deliver blood deep into developing tissues. There hasn’t been much success

Avinger tumbles on Q4 revenue miss

Shares in Avinger (NSDQ:AVGR) dropped today after the medical device maker missed expectations on Wall Street with its 4th quarter results. The Redwood City, Calif.-based company posted losses of -$13.5 million, or -58¢ per share, on sales of $4.7 million for the 3 months ended Dec. 31, for bottom-line loss of -0.3% on sales growth of 64% compared

Nanoengineers 3D-print biomimetic blood vessel networks

University of California San Diego researchers have 3D-printed a functional blood vessel network that they believe could someday be used in artificial organs and regenerative medicines. The team’s work was published in Biomaterials. Previous work in the field has yielded simple and costly structures, the researchers said, that are not capable of integrating with the body’s own

Intact Vascular wins CE Mark for Tack blood vessel repair device

Intact Vascular said today that it won CE Mark approval in the European Union for its Tack endovascular system to repair arterial dissections after percutaneous transluminal angioplasty below the knee. The indication extends the system’s use in the EU to the tibial arteries between the knee and the ankle. The Tack implant can be used in arteries ranging from

Mitral versus aortic valves: Here’s another reason they’re different

Aortic and mitral heart valves use different strategies to stay alive when they become cut off from oxygen and diseased, according to new research out of Rice University. The findings surprised the Rice bioengineers, led by professor Jane Grande-Allen, who used both physical and computer models of heart valves in their study. They custom-designed bioreactors

MOCACARE expands heart health portfolio with MOCACuff, a state-of-the-art blood pressure cuff worn on the cuff

MOCACARE, a Silicon Valley-based company at the heart of the connected health movement, has expanded its range of advanced, yet super simple, cardiovascular monitoring devices with the launch of MOCACuff, a sleek FDA-approved wireless blood pressure monitor that fits comfortably on the wrist. Priced at $69.99 USD, MOCACuff is designed with style and comfort in

Aerotel to present single-lead handheld ECG device at MEDICA 2016

Aerotel Medical Systems, a global vendor of advanced remote patient monitoring solutions, will introduce its HeartOne V, a state-of-the-art, single-lead, handheld ECG device at MEDICA 2016, which will take place from November 14 to 17, 2016 in Dusseldorf, Germany. Aerotel will showcase for the first time the digital version of its well-known HeartOne high-resolution single-lead

Bionet America introduces new and improved Cardio7 (ECG)

Bionet America, announces the launch of the new and improved Cardio7 (ECG), their latest addition to their ECG line. The Cardio7 is a reliable, interpretive, resting ECG. It features a large 7 in. TFT LCD touch screen with WiFi. It supports USB flash drive, a QWERTY keyboard, JPEG/PDF file format, one channel long-term recording and

Technology may aid at-home heart attack diagnosis, patient monitoring

Blood-glucose monitoring devices have revolutionized the management of diabetes by making it easy for ordinary individuals to test their glucose levels at home. But there are no similar consumer devices for cardiovascular disease, specifically for the quick and easy diagnosis of a heart attack. “The onset of heart attack symptoms is usually gradual, over several minutes,”

Dutch Mellon Medical unveils major innovation in surgical suture technology: Single-handed suturing using the Switch

Mellon Medical is unveiling a patented ground-breaking global innovation in suturing technology. The company has developed a platform technology for suturing with a single hand. The Switch, a disposable precision-suturing instrument, enables surgeons to suture tubular and layered structures about twice as fast as the conventional technique. The technology is expected to reduce the risk

New wireless heart pump makes no contact with blood

Scientists at Switzerland’s École Polytechnique Fédérale de Lausanne developed a completely new type of heart pump that does not make any contact with blood. There are a number of pumps on the market, including total heart replacements and left-ventricular assist devices, but they all can damage red blood cells. Moreover, the turbulence produced by the pumps can